Genetic testing for retinal dystrophies and dysfunctions: benefits, dilemmas and solutions
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Human retinal dystrophies have unparalleled genetic and clinical diversity and are currently linked to more than 185 genetic loci. Genotyping is a crucial exercise, as human gene‐specific clinical trials to study photoreceptor rescue are on their way. Testing confirms the diagnosis at the molecular level and allows for a more precise prognosis of the possible future clinical evolution. As treatments are gene‐specific and the ‘window of opportunity’ is time‐sensitive; accurate, rapid and cost‐effective genetic testing will play an ever‐increasing crucial role. The gold standard is sequencing but is fraught with excessive costs, time, manpower issues and finding non‐pathogenic variants. Therefore, no centre offers testing of all currently 132 known genes. Several new micro‐array technologies have emerged recently, that offer rapid, cost‐effective and accurate genotyping. The new disease chips from Asper Ophthalmics (for Stargardt dystrophy, Leber congenital amaurosis [LCA], Usher syndromes and retinitis pigmentosa) offer an excellent first pass opportunity. All known mutations are placed on the chip and in 4 h a patient's DNA is screened. Identification rates (identifying at least one disease‐associated mutation) are currently ∼70% (Stargardt), ∼60–70% (LCA) and ∼45% (Usher syndrome subtype 1). This may be combined with genotype–phenotype correlations that suggest the causal gene from the clinical appearance (e.g. preserved para‐arteriolar retinal pigment epithelium suggests the involvement of the CRB1 gene in LCA). As ∼50% of the retinal dystrophy genes still await discovery, these technologies will improve dramatically as additional novel mutations are added. Genetic testing will then become standard practice to complement the ophthalmic evaluation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202 · cited 2×
“Replacement of a RPE gene that encodes a retinoid cycle enzyme (RPE65) To determine whether gene replacement would work in a larger animal model, Acland et al.3 studied the effects of RPE65 replacement in the Briard dog.”
BackgroundHanein, S., Perrault, I., Gerber, S., Tanguy, G., Barbet, F., Ducroq, D., Calvas, P., Dollfus, H., Hamel, C., Lopponen, T., et al. (2004) · Human Mutation · doi:10.1002/humu.20010 · Cited by 350 · cited 1×
“5% efficiency is reached (Hanein et al.(24)).”
Van Hooser, J. P., Aleman, T. S., He, Y.-G., Cideciyan, A. V., Kuksa, V., Pittler, S. J., Stone, E. M., Jacobson, S. G., & Palczewski, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150236297 · Cited by 252
Cited by
Leber congenital amaurosis: Genes, proteins and disease mechanisms
den Hollander, A. I., Roepman, R., Koenekoop, R. K., & Cremers, F. P. M. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.05.003 · Cited by 811
Self-citationThe molecular basis of human retinal and vitreoretinal diseases
Berger, W., Kloeckener-Gruissem, B., & Neidhardt, J. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.03.004 · Cited by 594
Abu-Safieh, L., Alrashed, M., Anazi, S., Alkuraya, H., Khan, A. O., Al-Owain, M., Al-Zahrani, J., Al-Abdi, L., Hashem, M., Al-Tarimi, S., et al. (2013) · Genome Research · doi:10.1101/gr.144105.112 · Cited by 276
Kimberling, W. J., Hildebrand, M. S., Shearer, A. E., Jensen, M. L., Halder, J. A., Trzupek, K., Cohn, E. S., Weleber, R. G., Stone, E. M., & Smith, R. J. H. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181e5afb8 · Cited by 270
Diagnostic Challenges in Retinitis Pigmentosa: Genotypic Multiplicity and Phenotypic Variability
Chang, S., Vaccarella, L., Olatunji, S., Cebulla, C., & Christoforidis, J. (2011) · Current Genomics · doi:10.2174/138920211795860116 · Cited by 78
Metadata
- Authors
- Koenekoop, R. K., Lopez, I., Den Hollander, A. I., Allikmets, R., & Cremers, F. P.
- Venue
- Clinical & Experimental Ophthalmology
- Publisher
- Wiley
- Published
- 2007-07
- Volume
- 35
- Issue
- 5
- Pages
- 473-485
- ISSN
- 1442-6404 (ISSN-L)
- 1442-9071
- OpenAlex
- W2150467649
- Cited by
- 125
- References
- 3
- FWCI
- 4.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic testing for retinal dystrophies and dysfunctions: benefits, dilemmas and solutions. https://app.cochat.ai/papers/10.1111/j.1442-9071.2007.01534.x
- The paper
- Koenekoop, R. K., Lopez, I., Den Hollander, A. I., Allikmets, R., & Cremers, F. P. (2007). Genetic testing for retinal dystrophies and dysfunctions: benefits, dilemmas and solutions. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/j.1442-9071.2007.01534.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.